Q3 2026 Holdings
Filed 2026-10-29 | 2336 holdings | $57.1B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-11-03) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Novanta Inc(NOVT) | COM | 67000B104 | $71.4K | 502 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $71.7K | 2,367 | 0.0% |
| Bath & Body Works Inc(BBWI) | COM | 070830104 | $72.1K | 4,526 | 0.0% |
| Mirion Technologies Inc(MIR) | COM CL A | 60471A101 | $72.9K | 5,160 | 0.0% |
| Xpel Inc(XPEL) | COM | 98379L100 | $72.9K | 1,650 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $75.2K | 1,461 | 0.0% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $75.3K | 752 | 0.0% |
| NOV Inc(NOV) | COM | 62955J103 | $75.4K | 4,027 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $75.7K | 5,038 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $76.0K | 1,513 | 0.0% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $76.3K | 2,520 | 0.0% |
| Genpact Limited(G) | SHS | G3922B107 | $76.8K | 2,361 | 0.0% |
| Science Applications Intl Co(SAIC) | COM | 808625107 | $76.9K | 603 | 0.0% |
| Monro Inc(MNRO) | COM | 610236101 | $76.9K | 5,500 | 0.0% |
| Oshkosh Corp(OSK) | COM | 688239201 | $77.2K | 599 | 0.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $77.2K | 2,839 | 0.0% |
| Banco Santander Chile New(BSAC) | SP ADR REP COM | 05965X109 | $77.8K | 2,333 | 0.0% |
| Noah Hldgs LTD(NOAH) | SPON ADS | 65487X102 | $78.0K | 9,867 | 0.0% |
| Compania de Minas Buenaventu(BVN) | SPONSORED ADR | 204448104 | $78.2K | 2,475 | 0.0% |
| Innoviva Inc(INVA) | COM | 45781M101 | $78.3K | 3,692 | 0.0% |
| Xperi Inc(XPER) | COMMON STOCK | 98423J101 | $79.2K | 14,367 | 0.0% |
| Mohawk Inds Inc(MHK) | COM | 608190104 | $80.7K | 647 | 0.0% |
| Toro Co(TTC) | COM | 891092108 | $80.9K | 839 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $81.1K | 16,651 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $82.4K | 3,508 | 0.0% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $82.4K | 2,452 | 0.0% |
| Tetra Tech Inc New(TTEK) | COM | 88162G103 | $82.4K | 2,502 | 0.0% |
| Range RES Corp(RRC) | COM | 75281A109 | $84.3K | 2,277 | 0.0% |
| C3 AI Inc(AI) | CL A | 12468P104 | $84.5K | 7,691 | 0.0% |
| Ibex LTD(IBEX) | SHS NEW | G4690M101 | $84.5K | 1,954 | 0.0% |
| Vnet Group Inc(VNET) | SPONSORED ADS A | 90138A103 | $84.9K | 15,292 | 0.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $85.1K | 6,843 | 0.0% |
| Coca-Cola Femsa SAB de CV(KOF) | SPONS ADS REP | 191241108 | $85.1K | 788 | 0.0% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $85.2K | 1,173 | 0.0% |
| Transunion(TRU) | COM | 89400J107 | $85.4K | 1,398 | 0.0% |
| Blue OWL Capital Inc(OWL) | COM CL A | 09581B103 | $85.5K | 9,410 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $85.6K | 3,545 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $85.7K | 3,297 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $85.8K | 4,563 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $86.1K | 11,223 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $86.4K | 7,161 | 0.0% |
| LKQ Corp(LKQ) | COM | 501889208 | $86.6K | 3,795 | 0.0% |
| Gamestop Corp(GME) | CL A | 36467W109 | $86.9K | 3,524 | 0.0% |
| Medline Inc(MDLN) | COM CL A | 58507V107 | $87.2K | 2,514 | 0.0% |
| Maplebear Inc(CART) | COM | 565394103 | $87.4K | 2,027 | 0.0% |
| Stepstone Group Inc(STEP) | COM CL A | 85914M107 | $88.5K | 2,040 | 0.0% |
| Personalis Inc(PSNL) | COM | 71535D106 | $88.9K | 5,458 | 0.0% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $89.1K | 9,317 | 0.0% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $89.8K | 3,331 | 0.0% |
| Epam SYS Inc(EPAM) | COM | 29414B104 | $90.2K | 832 | 0.0% |